Related references
Note: Only part of the references are listed.Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Elena B. Pasquale
NATURE REVIEWS CANCER (2010)
Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex
Juha P. Himanen et al.
EMBO REPORTS (2009)
Characterization of Enantiomeric Bile Acid-induced Apoptosis in Colon Cancer Cell Lines
Bryson W. Katona et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer
Q. Chang et al.
BRITISH JOURNAL OF CANCER (2008)
Eph-ephrin bidirectional signaling in physiology and disease
Elena B. Pasquale
CELL (2008)
Small Molecules Can Selectively Inhibit Ephrin Binding to the EphA4 and EphA2 Receptors
Roberta Noberini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Targeting bile-acid signalling for metabolic diseases
Charles Thomas et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor
J. Wykosky et al.
ONCOGENE (2008)
Tissue transglutaminase clusters soluble A-type ephrins into functionally active high molecular weight oligomers
Spencer C. Alford et al.
EXPERIMENTAL CELL RESEARCH (2007)
Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids
Bryson W. Katona et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors
Cynthia Kosinski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice
Dana M. Brantley-Sieders et al.
CANCER RESEARCH (2006)
The EphB4 receptor-tyrosine kinase promotes the migration of melanoma cells through Rho-mediated actin cytoskeleton reorganization
Nai-Ying Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway - Implications for vasculogenic mimicry
AR Hess et al.
CANCER BIOLOGY & THERAPY (2006)
EphA2 phosphorylates the cytoplasmic tail of claudin-4 and mediates paracellular permeability
M Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis
W Bin Fang et al.
ONCOGENE (2005)
A conditional feedback loop regulates Ras activity through EphA2
M Macrae et al.
CANCER CELL (2005)
EPH receptor signalling casts a wide net on cell behaviour
EB Pasquale
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling
JP Himanen et al.
NATURE NEUROSCIENCE (2004)
Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist
P Dobrzanski et al.
CANCER RESEARCH (2004)
Quantitative methods for the analysis of protein phosphorylation in drug development
DM Olive
EXPERT REVIEW OF PROTEOMICS (2004)
A G protein-coupled receptor responsive to bile acids
Y Kawamata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma
T Miyazaki et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
An ephrin mimetic peptide that selectively targets the EphA2 receptor
M Koolpe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
β-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/EphrinB
E Batlle et al.
CELL (2002)
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
DM Brantley et al.
ONCOGENE (2002)
Mechanisms and functions of EPH and ephrin signalling
K Kullander et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation
H Miao et al.
NATURE CELL BIOLOGY (2000)
Share Paper
